{"id":45646,"date":"2022-06-29T17:01:37","date_gmt":"2022-06-29T15:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/"},"modified":"2022-06-29T17:01:37","modified_gmt":"2022-06-29T15:01:37","slug":"hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/","title":{"rendered":"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Next-generation RNA technology can be safer, more effective at lower doses than current mRNA COVID-19 vaccines<\/i>\n<\/p>\n<p class=\"bwalignc\">\n<i>Proprietary LION<sup>TM<\/sup> delivery system provides stability at refrigerator temperature<\/i>\n<\/p>\n<p>SEATTLE&#8211;(BUSINESS WIRE)&#8211;Indian regulators have issued an Emergency Use Approval for Gemcovac, a groundbreaking COVID-19 vaccine based on the technology of Seattle biotech HDT Bio Corp. The vaccine uses self-amplifying RNA (or \u201csaRNA\u201d), which replicates itself following administration and is thus effective at extremely low doses. In addition, it is stable at refrigerator temperatures\u2014unlike current mRNA vaccines, which require ultra-cold storage.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/5\/HDTBio_logo_%283%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/21\/HDTBio_logo_%283%29.jpg\"><\/a><\/p>\n<p>\n\u201cOur saRNA vaccine is a game changer,\u201d said HDT Bio CEO Steve Reed. \u201cThis technology can stimulate an immune response with a dose of up to 20 times lower than current vaccines, which enhances safety, lowers costs, and increases production speed. Also, the vaccine can be transported at refrigerator temperature, or even freeze-dried and shipped without temperature control. The combination of lower cost and higher stability will allow HDT Bio to take a truly global distribution approach.\u201d\n<\/p>\n<p>\nWith today\u2019s action by Indian regulators, Gemcovac becomes the first saRNA vaccine ever approved for human use. HDT Bio\u2019s vaccine is currently undergoing clinical trials in the U.S., Brazil, and South Korea.\n<\/p>\n<p>\n\u201cPandemics can&#8217;t be stopped without global access to quality vaccines. We are very excited that our vaccine will soon be saving lives, including in countries that have previously had limited access to advanced vaccine technologies,\u201d said Reed. \u201cThis milestone is the first of our many efforts to improve global health outcomes through scientific advancement.\u201d\n<\/p>\n<p>\n<b>ABOUT HDT BIO CORP.<\/b>\n<\/p>\n<p>\nHDT Bio is a biopharmaceutical company dedicated to providing immunotherapies to people around the world, including those in historically underserved areas. The company seeks to harness the body\u2019s immune system to deliver therapies that narrowly target the specific areas of the body where they are needed. HDT Bio\u2019s work focuses on oncological and infectious disease applications.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nChristopher M. Pirie, Ph.D.<br \/>\n<br \/>(425)-241-4152<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x63;&#104;r&#x69;&#115;&#x74;&#111;p&#x68;&#101;&#x72;&#x2e;p&#x69;&#114;i&#x65;&#64;&#x68;&#100;t&#x2e;&#98;&#x69;&#111;\" rel=\"nofollow noopener\" shape=\"rect\">&#x63;&#x68;&#114;is&#x74;&#x6f;&#112;&#104;e&#x72;&#x2e;&#112;&#105;r&#x69;&#x65;&#x40;&#104;dt&#x2e;&#x62;&#105;&#111;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Next-generation RNA technology can be safer, more effective at lower doses than current mRNA COVID-19 vaccines Proprietary LIONTM delivery system provides stability at refrigerator temperature SEATTLE&#8211;(BUSINESS WIRE)&#8211;Indian regulators have issued an Emergency Use Approval for Gemcovac, a groundbreaking COVID-19 vaccine based on the technology of Seattle biotech HDT Bio Corp. The vaccine uses self-amplifying RNA &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45646","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Next-generation RNA technology can be safer, more effective at lower doses than current mRNA COVID-19 vaccines Proprietary LIONTM delivery system provides stability at refrigerator temperature SEATTLE&#8211;(BUSINESS WIRE)&#8211;Indian regulators have issued an Emergency Use Approval for Gemcovac, a groundbreaking COVID-19 vaccine based on the technology of Seattle biotech HDT Bio Corp. The vaccine uses self-amplifying RNA ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-29T15:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/21\/HDTBio_logo_%283%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India\",\"datePublished\":\"2022-06-29T15:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/\"},\"wordCount\":338,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005703\\\/en\\\/1500843\\\/21\\\/HDTBio_logo_%283%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/\",\"name\":\"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005703\\\/en\\\/1500843\\\/21\\\/HDTBio_logo_%283%29.jpg\",\"datePublished\":\"2022-06-29T15:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005703\\\/en\\\/1500843\\\/21\\\/HDTBio_logo_%283%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005703\\\/en\\\/1500843\\\/21\\\/HDTBio_logo_%283%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/","og_locale":"en_US","og_type":"article","og_title":"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India - Pharma Trend","og_description":"Next-generation RNA technology can be safer, more effective at lower doses than current mRNA COVID-19 vaccines Proprietary LIONTM delivery system provides stability at refrigerator temperature SEATTLE&#8211;(BUSINESS WIRE)&#8211;Indian regulators have issued an Emergency Use Approval for Gemcovac, a groundbreaking COVID-19 vaccine based on the technology of Seattle biotech HDT Bio Corp. The vaccine uses self-amplifying RNA ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-29T15:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/21\/HDTBio_logo_%283%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India","datePublished":"2022-06-29T15:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/"},"wordCount":338,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/21\/HDTBio_logo_%283%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/","url":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/","name":"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/21\/HDTBio_logo_%283%29.jpg","datePublished":"2022-06-29T15:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/21\/HDTBio_logo_%283%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220629005703\/en\/1500843\/21\/HDTBio_logo_%283%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hdt-bios-covid-19-vaccine-wins-regulatory-approval-in-india\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"HDT Bio\u2019s COVID-19 Vaccine Wins Regulatory Approval in India"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45646"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45646\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}